| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hexosyltransferase activity | 9.70e-06 | 211 | 47 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.93e-05 | 153 | 47 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 3.24e-05 | 4 | 47 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 5.58e-05 | 288 | 47 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.59e-05 | 35 | 47 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | primary methylamine oxidase activity | 1.93e-04 | 9 | 47 | 2 | GO:0008131 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 2.22e-04 | 50 | 47 | 3 | GO:0004864 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 2.79e-04 | 54 | 47 | 3 | GO:0019212 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 3.77e-04 | 766 | 47 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 6.37e-04 | 16 | 47 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | quinone binding | 7.21e-04 | 17 | 47 | 2 | GO:0048038 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 1.00e-03 | 20 | 47 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 1.68e-03 | 100 | 47 | 3 | GO:0019888 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 2.39e-03 | 113 | 47 | 3 | GO:0019208 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 4.40e-03 | 42 | 47 | 2 | GO:0051721 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation via asparagine | 2.31e-05 | 24 | 48 | 3 | GO:0018279 | |
| Domain | - | 1.86e-05 | 3 | 47 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 1.86e-05 | 3 | 47 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 1.86e-05 | 3 | 47 | 2 | IPR015800 | |
| Domain | Cu_amine_oxidN2 | 1.86e-05 | 3 | 47 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 1.86e-05 | 3 | 47 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 1.86e-05 | 3 | 47 | 2 | IPR016182 | |
| Domain | Cu_amine_oxid | 1.86e-05 | 3 | 47 | 2 | PF01179 | |
| Domain | Cu_amine_oxidase_C | 1.86e-05 | 3 | 47 | 2 | IPR015798 | |
| Domain | COPPER_AMINE_OXID_1 | 1.86e-05 | 3 | 47 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 1.86e-05 | 3 | 47 | 2 | PS01165 | |
| Domain | UDPGT | 1.92e-05 | 21 | 47 | 3 | PF00201 | |
| Domain | UDPGT | 1.92e-05 | 21 | 47 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.92e-05 | 21 | 47 | 3 | IPR002213 | |
| Domain | Cu_amine_oxidase | 3.71e-05 | 4 | 47 | 2 | IPR000269 | |
| Domain | EGF-like_CS | 4.67e-05 | 261 | 47 | 6 | IPR013032 | |
| Domain | EGF_2 | 5.08e-05 | 265 | 47 | 6 | PS01186 | |
| Domain | LAM_G_DOMAIN | 1.18e-04 | 38 | 47 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.38e-04 | 40 | 47 | 3 | PF02210 | |
| Domain | LamG | 1.84e-04 | 44 | 47 | 3 | SM00282 | |
| Domain | EGF | 3.01e-04 | 235 | 47 | 5 | SM00181 | |
| Domain | EGF-like_dom | 3.93e-04 | 249 | 47 | 5 | IPR000742 | |
| Domain | WWE | 4.03e-04 | 12 | 47 | 2 | PS50918 | |
| Domain | WWE | 4.03e-04 | 12 | 47 | 2 | PF02825 | |
| Domain | WWE-dom | 4.03e-04 | 12 | 47 | 2 | IPR004170 | |
| Domain | Laminin_G | 4.18e-04 | 58 | 47 | 3 | IPR001791 | |
| Domain | EGF_1 | 4.38e-04 | 255 | 47 | 5 | PS00022 | |
| Domain | Galactose-bd-like | 1.71e-03 | 94 | 47 | 3 | IPR008979 | |
| Domain | - | 1.76e-03 | 95 | 47 | 3 | 2.60.120.200 | |
| Domain | TGFb_propeptide | 2.25e-03 | 28 | 47 | 2 | PF00688 | |
| Domain | TGF-b_N | 2.25e-03 | 28 | 47 | 2 | IPR001111 | |
| Domain | Abhydrolase_1 | 2.75e-03 | 31 | 47 | 2 | PF00561 | |
| Domain | EGF_3 | 2.85e-03 | 235 | 47 | 4 | PS50026 | |
| Domain | TGF-beta-rel | 2.93e-03 | 32 | 47 | 2 | IPR015615 | |
| Domain | TGFb_CS | 2.93e-03 | 32 | 47 | 2 | IPR017948 | |
| Domain | AB_hydrolase_1 | 3.11e-03 | 33 | 47 | 2 | IPR000073 | |
| Domain | TGFB | 3.90e-03 | 37 | 47 | 2 | SM00204 | |
| Domain | TGF-b_C | 3.90e-03 | 37 | 47 | 2 | IPR001839 | |
| Domain | TGF_BETA_2 | 3.90e-03 | 37 | 47 | 2 | PS51362 | |
| Domain | TGF_beta | 3.90e-03 | 37 | 47 | 2 | PF00019 | |
| Domain | TGF_BETA_1 | 3.90e-03 | 37 | 47 | 2 | PS00250 | |
| Domain | EGF | 3.92e-03 | 126 | 47 | 3 | PF00008 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.39e-05 | 219 | 38 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.45e-05 | 220 | 38 | 6 | M10320 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.52e-05 | 24 | 38 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.99e-05 | 25 | 38 | 3 | M17787 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.79e-04 | 41 | 38 | 3 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.22e-04 | 44 | 38 | 3 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.37e-04 | 45 | 38 | 3 | MM15694 | |
| Pubmed | Mutational screening of 10 genes in Chinese patients with microphthalmia and/or coloboma. | 2.94e-07 | 10 | 48 | 3 | 20057906 | |
| Pubmed | The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. | 1.87e-06 | 2 | 48 | 2 | 19588076 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27766585 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20724703 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 8333863 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 14585497 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 24020373 | ||
| Pubmed | Microphthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.43e-05 | 34 | 48 | 3 | 20301552 | |
| Pubmed | 1.59e-05 | 591 | 48 | 7 | 15231748 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 11744391 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20494911 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.38e-05 | 1201 | 48 | 9 | 35696571 | |
| Pubmed | Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. | 3.90e-05 | 7 | 48 | 2 | 9786991 | |
| Pubmed | Editing activity for eliminating mischarged tRNAs is essential in mammalian mitochondria. | 3.90e-05 | 7 | 48 | 2 | 29228266 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 26074487 | ||
| Pubmed | Murine cerberus homologue mCer-1: a candidate anterior patterning molecule. | 3.90e-05 | 7 | 48 | 2 | 9501024 | |
| Pubmed | 3.93e-05 | 276 | 48 | 5 | 28319085 | ||
| Pubmed | Bmp2 is required for cephalic neural tube closure in the mouse. | 5.19e-05 | 8 | 48 | 2 | 19097048 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 32093886 | ||
| Pubmed | Linkage analysis of 84 microsatellite markers in intra- and interspecific backcrosses. | 5.19e-05 | 8 | 48 | 2 | 1643308 | |
| Pubmed | The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. | 5.19e-05 | 8 | 48 | 2 | 13129926 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 10748067 | ||
| Pubmed | Eya1 gene dosage critically affects the development of sensory epithelia in the mammalian inner ear. | 5.19e-05 | 8 | 48 | 2 | 18678597 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 16790550 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 9988215 | ||
| Pubmed | Otx1 and Otx2 activities are required for the normal development of the mouse inner ear. | 6.67e-05 | 9 | 48 | 2 | 10225993 | |
| Pubmed | exma: an X-linked insertional mutation that disrupts forebrain and eye development. | 6.67e-05 | 9 | 48 | 2 | 11956759 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 17395647 | ||
| Pubmed | Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. | 6.67e-05 | 9 | 48 | 2 | 21596839 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 23521771 | ||
| Pubmed | 1.01e-04 | 65 | 48 | 3 | 33795231 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 12015300 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 9529255 | ||
| Pubmed | Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo. | 1.02e-04 | 11 | 48 | 2 | 18224709 | |
| Pubmed | Bmp4 from the optic vesicle specifies murine retina formation. | 1.02e-04 | 11 | 48 | 2 | 25792196 | |
| Pubmed | Induction of the mammalian node requires Arkadia function in the extraembryonic lineages. | 1.22e-04 | 12 | 48 | 2 | 11298452 | |
| Pubmed | Defects of the body plan of mutant embryos lacking Lim1, Otx2 or Hnf3beta activity. | 1.22e-04 | 12 | 48 | 2 | 11291865 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 12913075 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.33e-04 | 573 | 48 | 6 | 28330616 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 15961523 | ||
| Pubmed | The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. | 1.44e-04 | 13 | 48 | 2 | 16368929 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 9851982 | ||
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 19877283 | ||
| Pubmed | Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. | 1.44e-04 | 13 | 48 | 2 | 19841259 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 25775517 | ||
| Pubmed | Ino80 is essential for proximal-distal axis asymmetry in part by regulating Bmp4 expression. | 1.68e-04 | 14 | 48 | 2 | 26975355 | |
| Pubmed | Nuclear receptor NR5A2 is required for proper primitive streak morphogenesis. | 1.68e-04 | 14 | 48 | 2 | 17075876 | |
| Pubmed | Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. | 1.68e-04 | 14 | 48 | 2 | 14633973 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 15525667 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 23690951 | ||
| Pubmed | Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium. | 1.68e-04 | 14 | 48 | 2 | 17855431 | |
| Pubmed | Identification of Genes With Enriched Expression in Early Developing Mouse Cone Photoreceptors. | 1.94e-04 | 15 | 48 | 2 | 31260032 | |
| Pubmed | Tbx1 regulates population, proliferation and cell fate determination of otic epithelial cells. | 1.94e-04 | 15 | 48 | 2 | 17074316 | |
| Pubmed | Requirement for beta-catenin in anterior-posterior axis formation in mice. | 1.94e-04 | 15 | 48 | 2 | 10662781 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 10431240 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 11171400 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 15302604 | ||
| Pubmed | Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers. | 2.21e-04 | 16 | 48 | 2 | 16613831 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 12431380 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 20493948 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 15829521 | ||
| Pubmed | The mouse Ovol2 gene is required for cranial neural tube development. | 2.21e-04 | 16 | 48 | 2 | 16423343 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 24633704 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 15242798 | ||
| Pubmed | Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity. | 2.50e-04 | 17 | 48 | 2 | 12581525 | |
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 31315026 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 14695375 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 21886788 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 11884616 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 17634284 | ||
| Pubmed | Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. | 2.50e-04 | 17 | 48 | 2 | 20040491 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.75e-04 | 91 | 48 | 3 | 28558017 | |
| Pubmed | Epiblast-specific loss of HCF-1 leads to failure in anterior-posterior axis specification. | 2.81e-04 | 18 | 48 | 2 | 27521049 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 1765007 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 17936261 | ||
| Pubmed | Nodal signalling in the epiblast patterns the early mouse embryo. | 2.81e-04 | 18 | 48 | 2 | 11418863 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 15870281 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 15084457 | ||
| Pubmed | The Foxh1-dependent autoregulatory enhancer controls the level of Nodal signals in the mouse embryo. | 2.81e-04 | 18 | 48 | 2 | 12091315 | |
| Pubmed | 2.93e-04 | 93 | 48 | 3 | 27689697 | ||
| Pubmed | 3.13e-04 | 235 | 48 | 4 | 32614325 | ||
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 26685326 | ||
| Pubmed | Requirement for Lmo4 in the vestibular morphogenesis of mouse inner ear. | 3.14e-04 | 19 | 48 | 2 | 19913004 | |
| Pubmed | Gli3 is required for Emx gene expression during dorsal telencephalon development. | 3.14e-04 | 19 | 48 | 2 | 10409502 | |
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 20596238 | ||
| Pubmed | Proper patterning of the optic fissure requires the sequential activity of BMP7 and SHH. | 3.49e-04 | 20 | 48 | 2 | 16854970 | |
| Pubmed | Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. | 3.49e-04 | 20 | 48 | 2 | 15829518 | |
| Pubmed | Porcn-dependent Wnt signaling is not required prior to mouse gastrulation. | 3.49e-04 | 20 | 48 | 2 | 23760955 | |
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 10498685 | ||
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 3.49e-04 | 20 | 48 | 2 | 17107998 | |
| Pubmed | Extraembryonic proteases regulate Nodal signalling during gastrulation. | 3.85e-04 | 21 | 48 | 2 | 12447384 | |
| Pubmed | Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. | 3.85e-04 | 21 | 48 | 2 | 10421635 | |
| Pubmed | Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. | 3.85e-04 | 21 | 48 | 2 | 18781635 | |
| Pubmed | 4.07e-04 | 104 | 48 | 3 | 10470851 | ||
| Pubmed | The Wheels mutation in the mouse causes vascular, hindbrain, and inner ear defects. | 4.23e-04 | 22 | 48 | 2 | 11356033 | |
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 20965718 | ||
| Pubmed | Ets2 is necessary in trophoblast for normal embryonic anteroposterior axis development. | 4.23e-04 | 22 | 48 | 2 | 16481355 | |
| Pubmed | Specification of the mammalian cochlea is dependent on Sonic hedgehog. | 4.23e-04 | 22 | 48 | 2 | 12231626 | |
| Pubmed | Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. | 4.23e-04 | 22 | 48 | 2 | 18241853 | |
| Pubmed | NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. | 4.23e-04 | 22 | 48 | 2 | 19299468 | |
| Cytoband | 17q21 | 4.08e-05 | 63 | 48 | 3 | 17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.51e-03 | 473 | 48 | 4 | chr17q21 | |
| GeneFamily | UDP glucuronosyltransferases | 3.17e-05 | 32 | 35 | 3 | 363 | |
| Drug | isopentenyladenine | 1.38e-06 | 40 | 47 | 4 | CID000092180 | |
| Drug | isobutylamine | 1.79e-06 | 12 | 47 | 3 | CID000006558 | |
| Drug | diphenylglyoxal bis(guanylhydrazone | 4.17e-06 | 2 | 47 | 2 | CID000357080 | |
| Drug | AC1Q77R6 | 4.17e-06 | 2 | 47 | 2 | CID000094259 | |
| Drug | DPGBG | 4.17e-06 | 2 | 47 | 2 | CID005356884 | |
| Drug | monopropionylcadaverine | 4.17e-06 | 2 | 47 | 2 | CID000194207 | |
| Drug | p-dimethylaminomethylbenzaldehyde | 4.17e-06 | 2 | 47 | 2 | CID000193251 | |
| Drug | 1-carboxymethylpyridinium | 4.17e-06 | 2 | 47 | 2 | CID000080439 | |
| Drug | isoputreanine | 4.17e-06 | 2 | 47 | 2 | CID000171763 | |
| Drug | supinidine | 4.17e-06 | 2 | 47 | 2 | CID000164663 | |
| Drug | N-(3-aminopropyl)pyrrolidin-2-one | 4.17e-06 | 2 | 47 | 2 | CID000082111 | |
| Drug | AC1L1B7L | 1.25e-05 | 3 | 47 | 2 | CID000026477 | |
| Drug | 3-aminopropionamide | 1.25e-05 | 3 | 47 | 2 | CID000192802 | |
| Drug | pentafluorobenzamide | 1.25e-05 | 3 | 47 | 2 | CID000069547 | |
| Drug | acisoga | 1.25e-05 | 3 | 47 | 2 | CID000129397 | |
| Drug | (+)-Cyanustine | 1.25e-05 | 3 | 47 | 2 | CID000028846 | |
| Drug | propylglyoxal | 1.25e-05 | 3 | 47 | 2 | CID000123249 | |
| Drug | 3-Hydroxycadaverine | 1.25e-05 | 3 | 47 | 2 | CID000435285 | |
| Drug | 5-fluoropentane-1,4-diamine | 1.25e-05 | 3 | 47 | 2 | CID010011890 | |
| Drug | NSD-1531 | 1.25e-05 | 3 | 47 | 2 | CID003014318 | |
| Drug | Nazlinine | 1.25e-05 | 3 | 47 | 2 | CID000126237 | |
| Drug | 5-aminopentanal | 1.25e-05 | 3 | 47 | 2 | CID000443849 | |
| Drug | necic acid | 1.25e-05 | 3 | 47 | 2 | CID006440847 | |
| Drug | AC1L34PU | 1.25e-05 | 3 | 47 | 2 | CID000134498 | |
| Drug | manganese protoporphyrin | 1.25e-05 | 3 | 47 | 2 | ctd:C038654 | |
| Drug | h202 | 1.25e-05 | 3 | 47 | 2 | CID000013826 | |
| Drug | amicarbalide | 1.25e-05 | 3 | 47 | 2 | CID000072074 | |
| Drug | N-(4-aminobutyl)aziridine | 1.25e-05 | 3 | 47 | 2 | CID000152643 | |
| Drug | C10974 | 1.25e-05 | 3 | 47 | 2 | CID000443042 | |
| Drug | alpha-difluoromethyl putrescine | 1.25e-05 | 3 | 47 | 2 | CID000135151 | |
| Drug | ketosuccinamate | 1.25e-05 | 3 | 47 | 2 | CID000439716 | |
| Drug | N-(3-aminopropyl)aziridine | 1.25e-05 | 3 | 47 | 2 | CID000014076 | |
| Drug | ethylmethylglyoxal bis(guanylhydrazone | 1.25e-05 | 3 | 47 | 2 | CID000129202 | |
| Drug | malonamate | 2.50e-05 | 4 | 47 | 2 | CID000075367 | |
| Drug | 2-aminoresorcinol | 2.50e-05 | 4 | 47 | 2 | CID000069450 | |
| Drug | Eovist (TN) | 2.50e-05 | 4 | 47 | 2 | CID009961939 | |
| Drug | AC1Q3E6A | 2.50e-05 | 4 | 47 | 2 | CID000068318 | |
| Drug | spermic acid | 2.50e-05 | 4 | 47 | 2 | CID000167029 | |
| Drug | N-acetyl-1,6-diaminohexane | 2.50e-05 | 4 | 47 | 2 | CID000162081 | |
| Drug | 3-aminooxy-2-fluoro-1-propanamine | 2.50e-05 | 4 | 47 | 2 | CID000126496 | |
| Drug | 2-Butene-1,4-diamine | 2.50e-05 | 4 | 47 | 2 | CID000148401 | |
| Drug | lanthionamine | 2.50e-05 | 4 | 47 | 2 | CID000070096 | |
| Drug | N-methylpyrrolinium | 2.50e-05 | 4 | 47 | 2 | CID000440932 | |
| Drug | dimethylpyridine | 2.50e-05 | 4 | 47 | 2 | CID000011420 | |
| Drug | 1,4-diamino-2-butyne | 2.50e-05 | 4 | 47 | 2 | CID000124159 | |
| Drug | Cerebro | 2.60e-05 | 28 | 47 | 3 | CID000005354 | |
| Drug | tyrosine | 2.90e-05 | 29 | 47 | 3 | CID005460802 | |
| Drug | Ascorbic Acid | 3.90e-05 | 628 | 47 | 8 | ctd:D001205 | |
| Drug | piperideine | 4.15e-05 | 5 | 47 | 2 | CID000068161 | |
| Drug | geranylamine | 4.15e-05 | 5 | 47 | 2 | CID000160248 | |
| Drug | phenamidine | 4.15e-05 | 5 | 47 | 2 | CID000064948 | |
| Drug | NSD 1039 | 4.15e-05 | 5 | 47 | 2 | CID000193408 | |
| Drug | NSD 1024 | 4.15e-05 | 5 | 47 | 2 | CID000188951 | |
| Drug | N(8)-(2-carboxyethyl)spermidine | 4.15e-05 | 5 | 47 | 2 | CID000125245 | |
| Drug | Nsc82118 | 4.15e-05 | 5 | 47 | 2 | CID000164749 | |
| Drug | oxosparteine | 4.15e-05 | 5 | 47 | 2 | CID000097492 | |
| Drug | alpha-hydrazinohistidine | 4.15e-05 | 5 | 47 | 2 | CID000169499 | |
| Drug | perhydroazepinyl | 4.15e-05 | 5 | 47 | 2 | CID000123152 | |
| Drug | 2-fluoroputrescine | 4.15e-05 | 5 | 47 | 2 | CID000147066 | |
| Drug | pelletierine | 4.15e-05 | 5 | 47 | 2 | CID000092987 | |
| Drug | 1,4-diamino-2-butanone | 4.15e-05 | 5 | 47 | 2 | CID000151733 | |
| Drug | GGTI-286 | 5.15e-05 | 35 | 47 | 3 | CID003012116 | |
| Drug | norspermidine | 5.15e-05 | 35 | 47 | 3 | CID000005942 | |
| Drug | agmatine | 5.84e-05 | 102 | 47 | 4 | CID000000199 | |
| Drug | Olan | 6.22e-05 | 6 | 47 | 2 | CID000189047 | |
| Drug | NSC614854 | 6.22e-05 | 6 | 47 | 2 | CID000122633 | |
| Drug | isothiouronium | 6.22e-05 | 6 | 47 | 2 | CID000031429 | |
| Drug | trihydroxyphenylalanine | 6.22e-05 | 6 | 47 | 2 | CID000591034 | |
| Drug | cyclohexanone oxime | 6.22e-05 | 6 | 47 | 2 | CID000007517 | |
| Drug | 2-hydroxyestriol | 6.22e-05 | 6 | 47 | 2 | CID000014688 | |
| Drug | ethylglyoxal | 6.22e-05 | 6 | 47 | 2 | CID000145744 | |
| Drug | FF-705 | 6.22e-05 | 6 | 47 | 2 | CID000126643 | |
| Drug | 1,4-dimethylputrescine | 6.22e-05 | 6 | 47 | 2 | CID000162247 | |
| Drug | Fe(III)EDTA | 8.32e-05 | 41 | 47 | 3 | CID000028283 | |
| Drug | putreanine | 8.70e-05 | 7 | 47 | 2 | CID000161506 | |
| Drug | AC1L3Y6U | 8.70e-05 | 7 | 47 | 2 | CID000097282 | |
| Drug | GYKI 11.121 | 8.70e-05 | 7 | 47 | 2 | CID000193769 | |
| Drug | p-dimethylaminomethylbenzylamine | 8.70e-05 | 7 | 47 | 2 | CID000193714 | |
| Drug | 2-hydrazinopyridine | 8.70e-05 | 7 | 47 | 2 | CID000078645 | |
| Drug | AC1L28PE | 8.70e-05 | 7 | 47 | 2 | CID000067954 | |
| Drug | NADP(H | 9.65e-05 | 527 | 47 | 7 | CID000000930 | |
| Drug | hyamine hydroxide | 1.16e-04 | 8 | 47 | 2 | CID000014842 | |
| Drug | 1,2-diaminoguanidine | 1.16e-04 | 8 | 47 | 2 | CID000170039 | |
| Drug | NSC-356893 | 1.16e-04 | 8 | 47 | 2 | CID000434770 | |
| Drug | Z H-H | 1.16e-04 | 8 | 47 | 2 | CID000004657 | |
| Drug | Q 192 | 1.16e-04 | 8 | 47 | 2 | CID000077317 | |
| Drug | dolichols | 1.17e-04 | 122 | 47 | 4 | CID000439223 | |
| Drug | salicylamide | 1.34e-04 | 48 | 47 | 3 | CID000005147 | |
| Drug | imidazole | 1.39e-04 | 242 | 47 | 5 | CID000000795 | |
| Drug | p-nitrophenylhydrazine | 1.49e-04 | 9 | 47 | 2 | CID000069472 | |
| Drug | Lilly 51641 | 1.49e-04 | 9 | 47 | 2 | CID000021485 | |
| Drug | Farnezylacetone | 1.49e-04 | 9 | 47 | 2 | CID000061206 | |
| Drug | 4-acetamidobutyrate | 1.49e-04 | 9 | 47 | 2 | CID000018189 | |
| Drug | copper glycinate | 1.49e-04 | 9 | 47 | 2 | CID000424155 | |
| Drug | AC1L96SZ | 1.51e-04 | 50 | 47 | 3 | CID000439166 | |
| Drug | acetylcadaverine | 1.86e-04 | 10 | 47 | 2 | CID000189087 | |
| Drug | 6-hydroxydopa | 1.86e-04 | 10 | 47 | 2 | CID000033755 | |
| Drug | AC1O5218 | 1.86e-04 | 10 | 47 | 2 | CID006475722 | |
| Drug | 3-dimethylaminobenzoic acid | 1.86e-04 | 10 | 47 | 2 | CID000066837 | |
| Drug | isoxazolidine | 1.86e-04 | 10 | 47 | 2 | CID000136333 | |
| Disease | platelet-activating factor measurement | 2.27e-05 | 5 | 45 | 2 | EFO_0801075 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 2.27e-05 | 5 | 45 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | vanillylmandelate (VMA) measurement | 4.75e-05 | 7 | 45 | 2 | EFO_0800119 | |
| Disease | Microphthalmia associated with colobomatous cyst | 6.33e-05 | 8 | 45 | 2 | C2931501 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 8.13e-05 | 9 | 45 | 2 | EFO_0600040 | |
| Disease | Asthma, Occupational | 1.02e-04 | 10 | 45 | 2 | C0264423 | |
| Disease | cleft lip (is_implicated_in) | 2.36e-04 | 15 | 45 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.23e-04 | 215 | 45 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.53e-04 | 220 | 45 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.84e-04 | 225 | 45 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.10e-04 | 229 | 45 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | opioid dependence | 4.67e-04 | 237 | 45 | 4 | EFO_0005611 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.69e-04 | 21 | 45 | 2 | cv:C5680330 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.57e-04 | 105 | 45 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement | 6.61e-04 | 260 | 45 | 4 | EFO_0008317 | |
| Disease | uromodulin measurement | 7.22e-04 | 26 | 45 | 2 | EFO_0021778 | |
| Disease | Nephrotic Syndrome | 7.79e-04 | 27 | 45 | 2 | C0027726 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYVPMPTGIPHENIF | 76 | Q7L211 | |
| LPGEGIMPHEDGPLY | 106 | Q3KRA9 | |
| HMLSRPVPGYEPGYI | 1026 | P78357 | |
| PNLPFGYPVHGVEVM | 191 | Q8NHY0 | |
| YVAVMPPHIGDQPLT | 146 | P30043 | |
| VPLADMPHAPIGLYF | 76 | O95147 | |
| GTQPPGKMEYHLIPH | 476 | Q9Y2E6 | |
| YEVMKPPAEVVPGHL | 181 | P12644 | |
| LVVGPLPHPSYMRDV | 141 | Q16853 | |
| EMLFTLYPPEGAHVP | 426 | A0A1B0GVH7 | |
| AMYGDLPPPIMLIGH | 141 | Q9Y570 | |
| IKMADHYVPVPGGPN | 311 | O00763 | |
| ELVVGPLPHPSYMRD | 136 | O75106 | |
| VLPPMDGYPHCEGKI | 146 | Q09328 | |
| VPMYVGEIAPTHLRG | 156 | P14672 | |
| IGYMPIPVGVAGPLC | 531 | P04035 | |
| IYEVAIVGPIHPGME | 1876 | Q9NYQ8 | |
| HGRIPYPGMTNPEVI | 436 | P06239 | |
| APLYLGGLPEPMAVQ | 3641 | O15230 | |
| YHMVIAPGKGDIPPL | 106 | Q9H3R1 | |
| ARDTEMHPIPYPGGV | 331 | O60431 | |
| EEAPVLMHYPRGIPP | 266 | P23219 | |
| YLLTHPPPIMGGVVR | 1351 | Q7Z6Z7 | |
| MVGPDVIPLPHIYGA | 166 | Q15884 | |
| KRVVPGIVYLGHIPP | 41 | Q9ULW3 | |
| VFMAPPVHYPRGDGE | 166 | Q6ISB3 | |
| PHGYMELTIPPKNGD | 191 | O15229 | |
| EHYIPLNLPMPFGKG | 1076 | Q9BZ29 | |
| VEEGYRLPAPMGCPH | 851 | P29322 | |
| VVAPHNGYPVTPGIM | 16 | Q9BY19 | |
| NGYPVTPGIMSHVPL | 21 | Q9BY19 | |
| ILQAGDGPPQMRPYH | 256 | Q7Z6I6 | |
| GMDLLHPSVGYPATP | 21 | P32243 | |
| PGRGPRVVPHEYMLS | 86 | Q6KF10 | |
| IHGTALIGGLPMPYP | 281 | Q12972 | |
| HPLAYGMVGPLAQDP | 721 | Q9UKY4 | |
| PVLPTVHYNMGGIPT | 401 | P31040 | |
| PMPVPGHDVEAYCLL | 61 | Q9P0T7 | |
| GMPLAQPLVEHYVPR | 551 | Q9UN79 | |
| ALPLMVPDMAGYPHI | 846 | Q6ZNA4 | |
| HGIPMVGVPLFADQP | 386 | P06133 | |
| RHTSQGMGIPVLPYP | 1136 | Q9UPX0 | |
| GVYHGRIVLPPEYPM | 56 | Q9Y385 | |
| PMHCQVPGVEYPVGK | 1381 | Q9P273 | |
| EAIYHGIPMVGIPLF | 381 | P36537 | |
| HMEVMPLFAGYLPLP | 1146 | P48553 | |
| HGVPMVGIPLFGDQP | 381 | Q3SY77 | |
| YVLIPMLPAFEPGTG | 306 | Q63HR2 | |
| PQLIHGRDYEMVPEP | 551 | Q8NFA0 | |
| IGPDGHPLTVYPCMI | 411 | P08048 |